Company to Demonstrate Latest Advancements in Causal Machine Learning and AI for Trial Design and Predictive Analysis for Clinical Trial Success</ ...

In January 2025, EzFill, NextNRG’s mobile fueling division, reported $5 million in revenue, up 136% year-over-year from ...

Newronika, a leader in neuromodulation and adaptive deep brain stimulation (DBS) technology, announced today that it has received CE Mark approval for its AlphaDBS device, a next-generation ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate clinical development of ...